NDC Package 68001-451-06 Ziprasidone Hydrochloride

Capsule Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
68001-451-06
Package Description:
60 CAPSULE in 1 BOTTLE
Product Code:
Proprietary Name:
Ziprasidone Hydrochloride
Non-Proprietary Name:
Ziprasidone Hydrochloride
Substance Name:
Ziprasidone Hydrochloride
Usage Information:
Ziprasidone capsules are indicated for the treatment of schizophrenia, as monotherapy for the acute treatment of bipolar manic or mixed episodes, and as an adjunct to lithium or valproate for the maintenance treatment of bipolar disorder. When deciding among the alternative treatments available for the condition needing treatment, the prescriber should consider the finding of ziprasidone’s greater capacity to prolong the QT/QTc interval compared to several other antipsychotic drugs [see Warnings and Precautions (5.3)].  Prolongation of the QTc interval is associated in some other drugs with the ability to cause torsade de pointes-type arrhythmia, a potentially fatal polymorphic ventricular tachycardia, and sudden death. In many cases this would lead to the conclusion that other drugs should be tried first.  Whether ziprasidone will cause torsade de pointes or increase the rate of sudden death is not yet known [see Warnings and Precautions (5.3)] Schizophrenia•Ziprasidone capsules are indicated for the treatment of schizophrenia in adults [see Clinical Studies (14.1)].Bipolar I Disorder (Acute Mixed or Manic Episodes and Maintenance Treatment as an Adjunct to Lithium or Valproate)•Ziprasidone capsules are indicated as monotherapy for the acute treatment of adults with manic or mixed episodes associated with bipolar I disorder [see Clinical Studies (14.2)].•Ziprasidone capsules is indicated as an adjunct to lithium or valproate for the maintenance treatment of bipolar I disorder in adults [see Clinical Studies (14.2)].
11-Digit NDC Billing Format:
68001045106
NDC to RxNorm Crosswalk:
  • RxCUI: 313776 - ziprasidone HCl 40 MG Oral Capsule
  • RxCUI: 313776 - ziprasidone 40 MG Oral Capsule
  • RxCUI: 313776 - ziprasidone (as ziprasidone hydrochloride monohydrate) 40 MG Oral Capsule
  • RxCUI: 313777 - ziprasidone HCl 60 MG Oral Capsule
  • RxCUI: 313777 - ziprasidone 60 MG Oral Capsule
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Bluepoint Laboratories
    Dosage Form:
    Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA204117
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    08-31-2020
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 68001-451-06?

    The NDC Packaged Code 68001-451-06 is assigned to a package of 60 capsule in 1 bottle of Ziprasidone Hydrochloride, a human prescription drug labeled by Bluepoint Laboratories. The product's dosage form is capsule and is administered via oral form.

    Is NDC 68001-451 included in the NDC Directory?

    Yes, Ziprasidone Hydrochloride with product code 68001-451 is active and included in the NDC Directory. The product was first marketed by Bluepoint Laboratories on August 31, 2020 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 68001-451-06?

    The 11-digit format is 68001045106. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-268001-451-065-4-268001-0451-06